This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Eudendron S.r.l., Universita′ Degli Studi Di Milano. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Francesco Airaghi: Innovator in Heterocyclic Derivatives
Introduction
Francesco Airaghi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic derivatives. His work focuses on therapeutic applications for various diseases, including cancer and neurodegenerative disorders.
Latest Patents
Francesco Airaghi holds 1 patent for his invention titled "Heterocyclic derivatives modulating activity of certain protein kinases." This patent describes novel heterocyclic derivatives with a general formula (I) and their therapeutic use for diseases such as cancer, inflammation, pain, autoimmune diseases, and neurodegenerative diseases like Alzheimer's and Parkinson's disease. The compounds of formula (I) are particularly useful for treating patients who do not respond to existing kinase inhibition therapies.
Career Highlights
Throughout his career, Francesco has worked with various organizations, including Eudendron S.r.l. and Università Degli Studi di Milano. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Francesco has collaborated with notable colleagues such as Mauro Angiolini and Fabio Zuccotto. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Francesco Airaghi is a distinguished inventor whose work in heterocyclic derivatives has the potential to transform therapeutic approaches for several challenging diseases. His contributions to medicinal chemistry continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile